Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_assertion type Assertion NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_head.
- NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_assertion description "[The causative medical treatment of patients with malignant endocrine pancreatic tumors and the MEN-1 trait include chemotherapy (streptozotocin plus 5-fluorouracil), interferons and the somatostatin analogue SMS 201-995.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_provenance.
- NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_assertion evidence source_evidence_literature NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_provenance.
- NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_assertion SIO_000772 2568120 NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_provenance.
- NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_assertion wasDerivedFrom befree-2016 NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_provenance.
- NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_assertion wasGeneratedBy ECO_0000203 NP1263589.RAWYzSvjPIPuu358V0ktvigT4k8WYQ89arvaOPce56QvE130_provenance.